Buscar en
Gastroenterología y Hepatología
Toda la web
Inicio Gastroenterología y Hepatología Implicación de la proteína HBx del virus de la hepatitis B en la respuesta inm...
Información de la revista
Vol. 26. Núm. 9.
Páginas 552-561 (Enero 2003)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 26. Núm. 9.
Páginas 552-561 (Enero 2003)
DOI: 10.1016/S0210-5705(03)70412-9
Acceso a texto completo
Implicación de la proteína HBx del virus de la hepatitis B en la respuesta inmune y la progresión tumoral
Visitas
...
E. Lara-Pezzia,*, R. Moreno-Oterob, M. López-Cabreraa
a Unidad de Biología Molecular. Hospital Universitario de La Princesa. Madrid. España
b Unidad de Hepatología. Hospital Universitario de La Princesa. Madrid. España
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
F.V. Chisari.
Viruses, immunity, and cancer: lessons from hepatitis B.
Am J Pathol, 156 (2000), pp. 1118-1132
[2.]
D.F. Schafer, M.F. Sorrell.
Hepatocellular carcinoma.
Lancet, 353 (1999), pp. 1253-1257
[3.]
A.H. Malik, W.M. Lee.
Chronic hepatitis B virus infection: treatment strategies for the next millennium.
Ann Intern Med, 132 (2000), pp. 723-731
[4.]
P. Tiollais, C. Pourcel, A. Dejean.
The hepatitis B virus.
Nature, 317 (1985), pp. 489-495
[5.]
A. Kekule, U. Lauer, M. Meyer, W. Caselmann, P. Hofsschneider, R. Koshy.
The pre S2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator.
Nature, 343 (1990), pp. 457-460
[6.]
D. Ganem, H.E. Varmus.
The molecular biology of the hepatitis B virus.
Annu Rev Biochem, 56 (1987), pp. 651-693
[7.]
M.A. Feitelson, L.X. Duan.
Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma.
Am J Pathol, 150 (1997), pp. 1141-1157
[8.]
J. Summers, W.S. Mason.
Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate.
Cell, 29 (1982), pp. 403-415
[9.]
S. Takada, H. Kido, A. Fukutomi, T. Mori, K. Koike.
Interaction of hepatitis B virus X protein with a serine protease, tryptase TL2 as an inhibitor.
Oncogene, 9 (1994), pp. 341-348
[10.]
S. Urban, E. Hildt, C. Eckerskorn, H. Sirma, A. Kekule, P.H. Hofschneider.
Isolation and molecular characterization of hepatitis B virus-X protein from a baculovirus expression system.
Hepatology, 26 (1997), pp. 1045-1053
[11.]
N. Scheck, R. Bartenschlager, C. Kuhn, H. Schaller.
Phosphorylation and rapid turnover of hepatitis B virus Xprotein expressed in HepG2 cells from a recombinant vaccinia virus.
Oncogene, 6 (1991), pp. 1735-1744
[12.]
S. Takada, K. Koike.
Three sites of the hepatitis B virus X protein cooperativaly interact with cellular proteins.
Virology, 205 (1994), pp. 503-510
[13.]
V. Kumar, N. Jayasuryan, R. Kumar.
A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function.
Proc Natl Acad Sci USA, 93 (1996), pp. 5647-5652
[14.]
S. Murakami, J. Cheong, S. Kaneko.
Human hepatitis virus X gene encodes a regulatory domain that represses transactivation of X protein.
J Biol Chem, 269 (1994), pp. 15118-15123
[15.]
Q. Su, C.H. Schroder, W.J. Hofmann, G. Otto, R. Pichlmayr, P. Bannasch.
Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas.
Hepatology, 27 (1998), pp. 1109-1120
[16.]
H. Sirma, R. Weil, O. Rosmorduc, S. Urban, A. Israel, D. Kremsdorf, et al.
Cytosol is the prime compartment of hepatitis B virus X protein where it colocalizes with the proteasome.
Oncogene, 16 (1998), pp. 2051-2063
[17.]
M. Dandri, J. Petersen, R.J. Stockert, T.M. Harris, C.E. Rogler.
Metabolic labeling of woodchuck hepatitis B virus X protein in naturally infected hepatocytes reveals a bimodal half-life and association with the nuclear framework.
J Virol, 72 (1998), pp. 9359-9364
[18.]
Z. Rahmani, K.W. Huh, R. Lasher, A. Siddiqui.
The hepatitis b virus X protein colocalizes to mitochondria with a human voltage-dependent anion channel, HVDAC3, and alters its transmembrane potential.
J Virol, 74 (2000), pp. 2840-2846
[19.]
G. Waris, K.W. Huh, A. Siddiqui.
Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-αB via oxidative stress.
Mol Cell Biol, 21 (2001), pp. 7721-7730
[20.]
S. Takada, Y. Shirakata, N. Kaneniwa, K. Koike.
Association of hepatitis B virus X protein with mitochondria causes mitochondrial aggregation at the nuclear periphery, leading to cell death.
Oncogene, 18 (1999), pp. 6965-6973
[21.]
M. Lopez-Cabrera, J. Letovsky, K.Q. Hu, A. Siddiqui.
Multiple liver-specific factors bind to the hepatitis B virus core/pregenomic promoter: transactivation and repression by CCAAT/enhancer binding protein.
Proc Natl Acad Sci USA, 87 (1990), pp. 5069-5073
[22.]
R. Dikstein, O. Faktor, R. Ben-Levy, Y. Shaul.
Functional organization of the hepatitis B virus enhancer.
Mol Cell Biol, 10 (1990), pp. 3682-3689
[23.]
O. Faktor, Y. Shaul.
The identification of hepatitis B virus X gene responsive elements reveals functional similarity of X and HTLV-I tax.
Oncogene, 5 (1990), pp. 867-872
[24.]
H. Nakatake, O. Chisaka, S. Yamamoto, K. Matsubara, R. Koshy.
Effect of X protein on transactivation of hepatitis B virus promoters and on viral replication.
Virology, 195 (1993), pp. 305-314
[25.]
A. Kekule, U. Lauer, L. Weiss, B. Luber, P. Hofsschneider.
Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway.
Nature, 361 (1993), pp. 742-745
[26.]
M. Doria, N. Klein, R. Lucito, R.J. Schneider.
The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors.
EMBO J, 14 (1995), pp. 4747-4757
[27.]
M.J. Bouchard, L.H. Wang, R.J. Schneider.
Calcium signaling by HBx protein in hepatitis B virus DNA replication.
Science, 294 (2001), pp. 2376-2378
[28.]
N.P. Klein, R.J. Schneider.
Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras.
Mol Cell Biol, 17 (1997), pp. 6427-6436
[29.]
N.P. Klein, M.J. Bouchard, L.H. Wang, C. Kobarg, R.J. Schneider.
Src kinases involved in hepatitis B virus replication.
EMBO J, 18 (1999), pp. 5019-5027
[30.]
J. Benn, R.J. Schneider.
Hepatitis virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signalling cascade.
Proc Natl Acad Sci USA, 91 (1994), pp. 10350-10354
[31.]
J. Benn, F. Su, M. Doria, R.J. Schneider.
Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-jun N-terminal mitogen-activated protein kinases.
J Virol, 70 (1996), pp. 4978-4985
[32.]
G. Natoli, M. Avantaggiati, P. Chirillo, P. Puri, A. Ianni, C. Balsano, et al.
Ras-and Raf-dependent activation of c-jun transcriptional activity by hepatitis B virustransactivator pX.
Oncogene, 9 (1994), pp. 2836-2843
[33.]
P. Chirillo, M. Falco, P.L. Puri, M. Artini, C. Balsano, M. Levrero, et al.
Hepatitis B virus pX activates NF-αB dependent transcription through a Raf-independent pathway.
J Virol, 70 (1996), pp. 641-646
[34.]
R. Lucito, R.J. Schneider.
Hepatitis B virus X protein activates transcription factor NF-αB without a requirement for protein kinase C.
J Virol, 1992 (1992), pp. 983-991
[35.]
Y-H Lee, Y. Yun.
HBx protein of hepatitis B virus activates Jak1-STAT signaling.
J Biol Chem, 273 (1998), pp. 25510-25515
[36.]
W.L. Shih, M.L. Kuo, S.E. Chuang, A.L. Cheng, S.L. Doong.
Hepatitis B virus X protein inhibits transforming growth factor-beta-induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway.
J Biol Chem, 275 (2000), pp. 25858-25864
[37.]
J. Huang, J. Kwong, E. Sun, T. Liang.
Proteosome complex as a potential cellular target of hepatis B virus X protein.
J Virol, 70 (1996), pp. 5582-5591
[38.]
D.K. Lee, S.H. Park, Y. Yi, S.G. Choi, C. Lee, W.T. Parks, et al.
The hepatitis B virus encoded oncoprotein pX amplifies TGFbeta family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis.
Genes Dev, 15 (2001), pp. 455-466
[39.]
Y.I. Lee, S. Lee, Y. Lee, Y.S. Bong, S.W. Hyun, Y.D. Yoo, et al.
The human hepatitis B virus transactivator X gene product regulates Sp1 mediated transcription of an insulin-like growth factor II promoter 4.
Oncogene, 16 (1998), pp. 2367-2380
[40.]
Y.D. Yoo, H. Ueda, K. Park, K.C. Flanders, Y.I. Lee, G. Jay, et al.
Regulation of transforming growth factor-β1 expression by the hepatitis B virus (HBV) X transactivator.
J Clin Invest, 97 (1996), pp. 388-395
[41.]
B.H. Choi, G.T. Park, H.M. Rho.
Interaction of hepatitis B viral X protein and CCAAT/enhancer-binding protein a synergistically activates the hepatitis B viral enhancer II/pregenomic promoter.
J Cell Biol, 274 (1999), pp. 2858-2865
[42.]
H.F. Maguire, J.P. Hoeffler, A. Siddiqui.
HBV X protein alters the DNA binding specificity of CREB and ATF-2 by proteinprotein interactions.
Science, 252 (1991), pp. 842-844
[43.]
I. Haviv, Y. Matza, Y. Shaul.
pX, the HBV-encoded coactivator, suppresses the phenotypes of TBP and TAFII250 mutants.
Genes Dev, 12 (1998), pp. 1217-1226
[44.]
Y. Lin, H. Tang, T. Nomura, D. Dorjsuren, N. Hayashi, W. Wei, et al.
The hepatitis B virus X protein is a co-activator of activated transcription that modulates the transcription machinery and distal binding activators.
J Biol Chem, 273 (1998), pp. 27097-27103
[45.]
I. Haviv, M. Shamay, G. Doitsh, Y. Shaul.
Hepatitis B virus pX targets TFIIB in transcription coactivation.
Mol Cell Biol, 18 (1998), pp. 1562-1569
[46.]
I. Qadri, J.W. Conaway, R.C. Conaway, J. Schaack, A. Siddiqui.
Hepatitis B virus transactivator protein, HBx, associates with the components of TFIIH and stimulates the DNA helicase activity of TFIIH.
Proc Natl Acad Sci USA, 93 (1996), pp. 10578-10583
[47.]
I. Qadri, H. Maguire, A. Siddiqui.
Hepatitis B virus transactivator protein X interacts with the TATA-binding protein.
Proc Natl Acad Sci USA, 92 (1995), pp. 1003-1007
[48.]
J. Cheong, M. Yi, Y. Lin, S. Murakami.
Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation.
EMBO J, 14 (1995), pp. 143-150
[49.]
D. Dorjsuren, Y. Lin, W. Wei, T. Yamashita, T. Nomura, N. Hayashi, et al.
RMP, a novel RNA polymerase II subunit 5-interacting protein, counteracts transactivation by hepatitis B virus X protein.
Mol Cell Biol, 18 (1998), pp. 7546-7555
[50.]
K. Reifenberg, H. Wilts, J. Lohler, P. Nusser, R. Hanano, L.G. Guidotti, et al.
The hepatitis B virus X protein transactivates viral core gene expression in vivo.
J Virol, 73 (1999), pp. 10399-10405
[51.]
D.F. Spandau, C.H. Lee.
Trans-activation of viral enhancers by the hepatitis B virus X protein.
J Virol, 62 (1988), pp. 427-434
[52.]
J.S. Twu, W.S. Robinson.
Hepatitis B virus X gene can transactivate heterologous viral sequences.
Proc Natl Acad Sci USA, 86 (1989), pp. 2046-2050
[53.]
M. Levrero, C. Balsano, G. Natoli, M.L. Avantaggiati, E. Elfassi.
Hepatitis B virus X protein transactivates the long terminal repeats of human immunodeficiency virus types 1 and 2.
J Virol, 64 (1990), pp. 3082-3086
[54.]
C. Ferrari, M. Pilli, A. Penna, A. Bertoletti, A. Valli, A. Cavalli, et al.
Autopresentation of hepatitis B virus envelope antigens by T cells.
J Virol, 66 (1992), pp. 2536-2540
[55.]
A. Franco, M. Paroli, U. Testa, R. Benvenuto, C. Peschle, F. Balsano, et al.
Transferrin receptor mediates up-take and presentation of hepatitis B envelope antigens by T cells.
J Exp Med, 175 (1992), pp. 1195-1205
[56.]
M. Gomez-Gonzalo, M. Carretero, J. Rullas, E. Lara-Pezzi, J. Aramburu, B. Berkhout, et al.
The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with Tcell activation signals: functional roles of NF-kappaB/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter.
J Biol Chem, 276 (2001), pp. 35435-35443
[57.]
A. Eskild, P. Magnus, G. Petersen, C. Sohlberg, F. Jensen, P. Kittelsen, et al.
Hepatitis B antibodies in HIV-infected homosexual men are associated with more rapid progression to AIDS.
AIDS, 6 (1992), pp. 571-574
[58.]
M.L. Avantaggiati, G. Natoli, C. Balsano, P. Chirillo, M. Artini, E.D. Marzio, et al.
The hepatitis B virus (HBV) pX transactivates the c-fos promoter through multiple cis-acting elements.
Oncogene, 8 (1993), pp. 1567-1574
[59.]
C. Balsano, M.L. Avantaggiati, G. Natoli, E.D. Marzio, H. Will, M. Perricaudet, et al.
Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the cmyc protooncogene at the transcriptional level.
Biochem Biophys Res Commun, 176 (1991), pp. 985-992
[60.]
S. Menzo, M. Clementi, E. Alfani, P. Bagnarelli, S. Iacovacci, A.M. Dandri, et al.
Trans-activation of epidermal growth factor receptor gene by the hepatitis B virus-X gene product.
Virology, 196 (1993), pp. 878-882
[61.]
D.K. Hsu, C.A. Dowling, K.C. Jeng, J.T. Chen, R.Y. Yang, F.T. Liu.
Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma.
Int J Cancer, 81 (1999), pp. 519-526
[62.]
S.O. Kim, J.G. Park, Y.I. Lee.
Increased expression of the Insulin-like groth factor I (IGF-I) receptor gene in hepatocelular carcinoma cell lines: implications of IGF-I receptor gene activation by hepatitis B virus X gene product.
Cancer Res, 56 (1996), pp. 3831-3836
[63.]
S.L. Feng, Y. Guo, V.M. Factor, S.S. Thorgeirsson, D.W. Bell, J.R. Testa, et al.
The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinoma.
Am J Pathol, 156 (2000), pp. 1253-1261
[64.]
E.C. Shin, J.S. Shin, J.H. Park, H. Kim, S.J. Kim.
Expression of Fas ligand in human hepatoma cell lines: role of hepatitis-B virus X (HBx) in induction of Fas ligand.
Int J Cancer, 82 (1999), pp. 587-591
[65.]
Y. Lee, U.S. Park, I. Choi, S.K. Yoon, Y.M. Park, Y.I. Lee.
Human interleukin 6 gene is activated by hepatitis B virus-X protein in human hepatoma cells.
Clin Cancer Res, 4 (1998), pp. 1711-1717
[66.]
K.Q. Hu, C.H. Yu, J.M. Vierling.
Up-regulation of intercellular adhesion molecule 1 transcription by hepatitis B virus X protein.
Proc Natl Acad Sci USA, 89 (1992), pp. 11441-11445
[67.]
K. Hu, J. Vierling, A. Siddiqui.
Trans-activation of HLA-DR gene by hepatitis B virus X gene product.
Proc Natl Acad Sci USA, 87 (1990), pp. 7140-7144
[68.]
M. Lee, Y. Choi, E. Shin, H. Kang, Y. Kim, S. Jeong, et al.
Hepatitis B virus X protein induced expression of interleukin 18 (IL-18): a potential mechanism for liver injury caused by hepatitis B virus (HBV) infection.
J Hepatol, 37 (2002), pp. 380
[69.]
B. Aufiero, R. Schneider.
The hepatitis B virus X-gene product trans-activates both RNA polymerase II and III promoters.
EMBO J, 9 (1990), pp. 497-504
[70.]
H.D. Wang, A. Trivedi, D.L. Johnson.
Regulation of RNA polymerase I-dependent promoters by the hepatitis B virus X protein via activated ras and TATA-binding protein.
Mol Cell Biol, 18 (1998), pp. 7086-7094
[71.]
H.S. Chen, S. Kaneko, R. Girones, R.W. Anderson, W.E. Hornbuckle, B.C. Tennant, et al.
The woodchuck hepatitis virus X gene is important for establishment of virus infection of woodchucks.
J Virol, 67 (1993), pp. 1218-1226
[72.]
F. Zoulim, J. Saputelli, C. Seeger.
Woodchuck hepatitis virus X protein is required for viral infection in vivo.
J Virol, 68 (1994), pp. 2026-2030
[73.]
F. Chisari, C. Ferrari.
Hepatitis B virus immunopathogenesis.
Annu Rev Immunol, 13 (1995), pp. 29-60
[74.]
L.G. Guidotti, K. Ando, M.V. Hobbs, T. Ishikawa, R.D. Runkel, R.D. Schreiber, et al.
Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice.
Proc Natl Acad Sci USA, 91 (1994), pp. 3764-3768
[75.]
L.G. Guidotti, T. Ishikawa, M.V. Hobbs, B. Matzke, R. Schreiber, F.V. Chisari.
Intracellular inactivation of the hepatitis B Virus by cytotoxic T lymphocytes.
Immunity, 4 (1996), pp. 25-36
[76.]
L.G. Guidotti, F.V. Chisari.
Noncytolytic control of viral infections by the innate and adoptive immune response.
Annu Rev Immunol, 19 (2001), pp. 65-91
[77.]
P. Vassalli.
The pathophysiology of tumor necrosis factor.
Annu Rev Immunol, 10 (1992), pp. 411-452
[78.]
K.J. Simpson, N.W. Lukacs, L. Colletti, R.M. Strieter, S.L. Kunkel.
Cytokines and the liver.
J Hepatol, 27 (1997), pp. 1120-1132
[79.]
P.L. Majano, C. Garcia-Monzon, M. Lopez-Cabrera, E. Lara-Pezzi, E. Fernandez-Ruiz, C. Garcia-Iglesias, et al.
Inducible nitric oxide synthase expression in chronic viral hepatitis.
J Clin Invest, 101 (1998), pp. 1343-1352
[80.]
L.G. Guidotti, H. McClary, J.M. Loudis, F.V. Chisari.
Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice.
J Exp Med, 191 (2001), pp. 1247-1252
[81.]
R.M. Rai, F.Y. Lee, A. Rosen, S.Q. Yang, H.Z. Lin, A. Koteish, et al.
Impaired liver regeneration in inducible nitric oxide synthase-deficient mice.
Proc Natl Acad Sci USA, 95 (1998), pp. 13829-13834
[82.]
F. Su, C.N. Theodosis, R.J. Schneider.
Role of NF-αB and Myc proteins in apoptosis induced by hepatitis B virus HBx protein.
[83.]
A.A. Beg, W.C. Sha, R.T. Bronson, S. Ghosh, D. Baltimore.
Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-αB.
Nature, 376 (1995), pp. 167-170
[84.]
J. Diao, R. Garces, C.D. Richardson.
X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathyways during the course of viral infections and hepatocarcinogenesis.
Cytokine Growth Factor Rev, 12 (2001), pp. 189-205
[85.]
G.G. Chen, P.B. Lai, P.K. Chan, E.C. Chak, J.H. Yip, R.L. Ho, et al.
Decreased expression of Bid in human hepatocellular carcinoma is related to hepatitis B virus X protein.
Arv, 37 (2001), pp. 1695-1702
[86.]
K. Gottlob, M. Fulco, M. Levrero, A. Graessmann.
The hepatitis B virus HBx protein inhibits caspase 3 activity.
J Biol Chem, 273 (1998), pp. 33347-33353
[87.]
J. Diao, A.A. Khine, F. Sarangi, E. Hsu, C. Iorio, L.A. Tibbles, et al.
X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated with up-regulation of the SAPK/JNK pathway.
J Biol Chem, 276 (2001), pp. 8328-8340
[88.]
X.W. Wang, M.K. Gibson, W. Vermeulen, K. Forrester, H. Yeh, H.W. Sturzbecher, et al.
Abrogation of p53-induced apoptosis by the hepatitis B virus X gene.
Cancer Res, 55 (1995), pp. 6012-6016
[89.]
E. Lara-Pezzi, P.L. Majano, M. Gomez-Gonzalo, C. Garcia-Monzon, R. Moreno-Otero, M. Levrero, et al.
Hepatitis B virus X protein up-regulates tumor necrosis factor-α gene expression in hepatocytes.
Hepatology, 28 (1998), pp. 1013-1021
[90.]
A.M. Diehl.
Cytokine regulation of liver injury and repair.
Immunol Rev, 174 (2000), pp. 160-171
[91.]
A. Alcami, U.H. Koszinowski.
Viral mechanisms of immune evasion.
Immunol Today, 21 (2000), pp. 447-455
[92.]
B.H. Davis, T.F. Kresina.
Hepatic fibrogenesis.
Clin Lab Med, 16 (1996), pp. 361-387
[93.]
Y. Nakamoto, L.G. Guidotti, C.V. Kuhlen, P. Fowler, F.V. Chisari.
Immune pathogenesis of hepatocellular carcinoma.
J Exp Med, 188 (1998), pp. 341-350
[94.]
F.V. Chisari, K. Klopchin, T. Moriyama, C. Pasquinelli, H.A. Dunsford, S. Sell, et al.
Molecular pathogenesis of hepatocelular carcinoma in hepatitis B virus transgenic mice.
Cell, 59 (1989), pp. 1145-1156
[95.]
H.A. Dunsford, S. Sell, F.V. Chisari.
Hepatocarcinogenesis due to chronic liver cell injury in hepatitis B virus transgenic mice.
Cancer Res, 50 (1990), pp. 3400-3407
[96.]
T.Y. Hsu, T. Moroy, J. Etiemble, A. Louise, C. Trepo, P. Tiollais, et al.
Activation of c-myc by woodchuck hepatitis virus insertion in hepatocellular carcinoma.
Cell, 55 (1988), pp. 627-635
[97.]
A. Dejean, P. Sonigo, S. Wain-Hobson, P. Tiollais.
Specific hepatitis B virus integration in hepatocellular carcinoma DNA through a viral 11-base-pair direct repeat.
Proc Natl Acad Sci USA, 81 (1984), pp. 5350-5354
[98.]
T. Matsubara, T. Tokina.
Integration of hepatitis B virus DNA and its implications for carcinogenesis.
Mol Biol Med, 7 (1990), pp. 243-260
[99.]
P. Paterlini, K. Poussin, M. Kew, D. Franco, C. Brechot.
Selective accumulation of the transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma.
Hepatology, 21 (1995), pp. 313-321
[100.]
S.F. Chang, H.J. Netter, E. Hildt, R. Schuster, S. Schaefer, Y.C. Hsu, et al.
Duck hepatitis B virus expresses a regulatory HBxlike protein from a hidden open reading frame.
[101.]
C.M. Kim, K. Koike, I. Saito, T. Miyamura, G. Jay.
HBx gene of hepatitis B virus induces liver cancer in transgenic mice.
Nature, 351 (1991), pp. 317-320
[102.]
D.Y. Yu, H.B. Moon, J.K. Son, S. Jeong, S.L. Yu, H. Yoon, et al.
Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein.
J Hepatol, 31 (1999), pp. 123-132
[103.]
O. Terradillos, O. Billet, C.A. Renard, R. Levy, T. Molina, P. Briand, et al.
The hepatitis B virus X gene potentiates cmyc-induced liver oncogenesis in transgenic mice.
Oncogene, 14 (1997), pp. 395-404
[104.]
B.L. Slagle, T.H. Lee, D. Medina, M.J. Finegold, J.S. Butel.
Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene.
[105.]
M. Hohne, S. Schaefer, M. Seifer, M.A. Feitelson, D. Paul, W.H. Gerlich.
Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA.
EMBO J, 9 (1990), pp. 1137-1145
[106.]
R. Truant, J. Antunovic, J. Greenblatt, C. Prives, J.A. Cromlish.
Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation.
J Virol, 69 (1995), pp. 1851-1859
[107.]
X.W. Wang, K. Forrester, H. Yeh, M.A. Feitelson, J.R. Gu, C.C. Harris.
Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3.
Proc Natl Acad Sci USA, 91 (1994), pp. 2230-2234
[108.]
S.A. Becker, T.H. Lee, J.S. Butel, B.L. Slagle.
Hepatitis B virus X Protein interferes with cellular DNA repair.
J Virol, 72 (1998), pp. 266-272
[109.]
S.W. Lee, Y.M. Lee, S.K. Bae, S. Murakami, Y. Yun, K.W. Kim.
Human hepatitis B virus X protein is a possible mediator of hypoxia-induced angiogenesis in hepatocarcinogenesis.
Biochem Biophys Res Commun, 268 (2000), pp. 456-461
[110.]
K. Koike, K. Moriya, H. Yotsuyanagi, S. Lino, K. Kurokawa.
Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts.
J Clin Invest, 94 (1994), pp. 44-49
[111.]
J. Benn, R.J. Schneider.
Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls.
Proc Natl Acad Sci USA, 92 (1995), pp. 11215-11219
[112.]
J.Y. Ahn, E.Y. Jung, H.J. Kwun, C.W. Lee, Y.C. Sung, K.L. Jang.
Dual effects of hepatitis B virus X protein on the regulation of cell-cycle control depending on the status of cellular p53.
J Gen Virol, 83 (2002), pp. 2765-2772
[113.]
E. Lara-Pezzi, J.M. Serrador, M.C. Montoya, D. Zamora, M. Yáñez-Mó, M. Carretero, et al.
The hepatitis B virus X protein (HBx) induces a migratory phenotype in a CD44-dependent manner: possible role of HBx in invasion and metastasis.
Hepatology, 33 (2001), pp. 1270-1281
[114.]
E. Lara-Pezzi, S. Roche, O.M. Andrisani, F. Sánchez-Madrid, M. López-Cabrera.
The hepatitis B virus HBx protein induces adherens junction disruption in a src-dependent manner.
Oncogene, 20 (2001), pp. 3323-3331
[115.]
E. Lara-Pezzi, P.L. Majano, M. Yáñez-Mo, M. Gómez-Gonzalo, M. Carretero, R. Moreno-Otero, et al.
Effect of the hepatitis B virus HBx protein on integrin-mediated adhesion to and migration on extracellular matrix.
J Hepatol, 34 (2001), pp. 409-415
[116.]
E. Lara-Pezzi, M.V. Gómez-Gaviro, B.G. Gálvez, E. Mira, M.A. Iñiguez, M. Fresno, et al.
The hepatitis B virus X protein promotes tumor cell invasion by inducing MT1-MMP and COX-2 expression.
J Clin Invest, 110 (2002), pp. 1831-1838
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.